Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1702018
PUBLISHER: IMARC | PRODUCT CODE: 1702018
Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2025-2033
PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global monoclonal antibodies market size reached USD 235.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 410.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.04% during 2025-2033. The rising prevalence of chronic disorders such as cancer, autoimmune disorders, and infectious diseases, innovations like bispecific antibodies and antibody-drug conjugates (ADCs), increasing geriatric population, and the expansion in oncology and immunotherapy are propelling the market growth.
Monoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targeting cancer cells for destruction by enhancing the immune system. They are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells
Monoclonal Antibodies Market Trends:
At present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer's, Huntington's, Parkinson's, and Lewy body diseases. They are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market. In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Moreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.
Key Market Segmentation:
Breakup by Production Method:
- In Vivo
- In Vitro
Breakup by Source:
- Murine
- Chimeric
- Humanized
- Human
Breakup by Indication:
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
Breakup by End Use:
- Hospitals
- Research Institutes
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1.What was the size of the global monoclonal antibodies market in 2024?
- 2.What is the expected growth rate of the global monoclonal antibodies market during 2025-2033?
- 3.What are the key factors driving the global monoclonal antibodies market?
- 4.What has been the impact of COVID-19 on the global monoclonal antibodies market?
- 5.What is the breakup of the global monoclonal antibodies market based on the production method?
- 6.What is the breakup of the global monoclonal antibodies market based on the source?
- 7.What is the breakup of the global monoclonal antibodies market based on the indication?
- 8.What is the breakup of the global monoclonal antibodies market based on the end use?
- 9.What are the key regions in the global monoclonal antibodies market?
- 10.Who are the key players/companies in the global monoclonal antibodies market?
Product Code: SR112025A6278
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Monoclonal Antibodies Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Production Method
- 6.1 In Vivo
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 In Vitro
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Source
- 7.1 Murine
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Chimeric
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Humanized
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Human
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Indication
- 8.1 Cancer
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Autoimmune Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Inflammatory Diseases
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Infectious Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by End Use
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 AbbVie Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Amgen Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Biogen Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 F. Hoffmann-La Roche AG
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 GSK plc
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Johnson & Johnson
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Merck KGaA
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Novartis AG
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Novo Nordisk A/S
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Sanofi S.A.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Thermo Fisher Scientific Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 AbbVie Inc.
Product Code: SR112025A6278
List of Figures
- Figure 1: Global: Monoclonal Antibodies Market: Major Drivers and Challenges
- Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2024
- Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2024
- Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2024
- Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2024
- Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2024
- Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2024
- Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
- Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
- Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Monoclonal Antibodies Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Monoclonal Antibodies Market Forecast: Breakup by Production Method (in Million USD), 2025-2033
- Table 3: Global: Monoclonal Antibodies Market Forecast: Breakup by Source (in Million USD), 2025-2033
- Table 4: Global: Monoclonal Antibodies Market Forecast: Breakup by Indication (in Million USD), 2025-2033
- Table 5: Global: Monoclonal Antibodies Market Forecast: Breakup by End Use (in Million USD), 2025-2033
- Table 6: Global: Monoclonal Antibodies Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Monoclonal Antibodies Market: Competitive Structure
- Table 8: Global: Monoclonal Antibodies Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.